Zimbabwe has rejected a substantial US healthcare agreement worth $367m (£272m) spanning five years over the United States' request for confidential information.
This rejection came to light after a internal memorandum dated December was leaked, which showed President Emmerson Mnangagwa believed the arrangement was "skewed".
An official spokesperson has since stated that the United States was requesting genetic material for scientific study and commercial gain while was not willing to guarantee the benefits from any future medical innovations.
"We will now turn to the challenging and unfortunate task of winding down our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had provided more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has appealed for continued dialogue to reach a agreement agreeable to both sides so the nation's critical HIV treatment initiative can be sustained.
Broader Context
This development follows a comparable situation in Kenya, where a high court halted a related deal with the US following legal challenges were raised about the security of citizens' health data.
Since returning to office last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump claimed its spending was "wasteful" and his government was pursuing government-to-government deals to boost transparency and accountability.
Based on statements, 16 nations in Africa have to date signed similar health pacts, constituting more than $18.3bn of fresh investment.
Specifics of the Rejected Deal
The funds for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation would have delivered immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently on HIV treatment via US-supported programmes," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"Our nation was requested to surrender its biological resources and data indefinitely, without any equivalent guarantee of access to any scientific breakthroughs – like new medicines or tests – that could be developed from that provided information," his statement read.
"Effectively, our nation would supply the basic resources for medical research without any certainty that the end products would be accessible to our population if a new health crisis emerge."
Sovereignty and International Frameworks
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting systems already set up via the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage future global health emergencies.
"This system is intended to ensure that when a country provides its samples, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised solely by those with the resources to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We welcome continued dialogue with our American counterparts on how future co-operation could be arranged in a manner that respects the sovereignty and dignity of each country."
Health Experts Response
Medical experts said it understood the official position, but suggested that negotiations should continue considering much of the country's Aids initiatives relied on external financing.
"If technical issues exist, such as those relating to information security or agreement terms, these can often be resolved through detailed discussion and mutually agreed protections," it said.
The situation highlights the complex debate between receiving crucial foreign assistance and protecting a country's data in an increasingly data-driven world.